Skip to main content
SpringerLink
Log in

Volume Overload in CKD: Pathophysiology, Assessment Techniques, Consequences and Treatment

  • Chapter
  • First Online:
Cardio-Renal Clinical Challenges

  • 1604 Accesses

Abstract

‘Fluid balance’ is generally defined by the difference between the daily fluid input and the daily fluid output and it should not be associated with weight and insensible losses, but it could be correlated with dialysis fluid removal if an individual is on renal replacement therapy (RRT) [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ronco C, Kaushik M, Valle R, Aspromonte N, Peacock 4th WF. Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the “5b” approach. Semin Nephrol. 2012;32:129–41.

    PubMed  Google Scholar 

  2. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009;119:671–9.

    PubMed Central  PubMed  Google Scholar 

  3. Agarwal R. Hypervolemia is associated with increased mortality among hemodialysis patients. Hypertension. 2010;56:512–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  4. van Biesen W, Claes K, Covic A, Fan S, Lichodziejewska-Niemierko M, Schoder V, Verger C, Wabel P. A multicentric, international matched pair analysis of body composition in peritoneal dialysis versus haemodialysis patients. Nephrol Dial Transplant. 2013;28:2620–8.

    PubMed  Google Scholar 

  5. Hung SC, Lin YP, Huang HL, Pu HF, Tarng DC. Aldosterone and mortality in hemodialysis patients: role of volume overload. PLoS One. 2013;8:e57511.

    CAS  PubMed Central  PubMed  Google Scholar 

  6. Bellizzi V, Scalfi L, Terracciano V, De Nicola L, Minutolo R, Marra M, Guida B, Cianciaruso B, Conte G, Di Iorio BR. Early changes in bioelectrical estimates of body composition in chronic kidney disease. J Am Soc Nephrol. 2006;17:1481–7.

    PubMed  Google Scholar 

  7. Essig M, Escoubet B, de Zuttere D, Blanchet F, Arnoult F, Dupuis E, Michel C, Mignon F, Mentre F, Clerici C, Vrtovsnik F. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. Nephrol Dial Transplant. 2008;23:239–48.

    CAS  PubMed  Google Scholar 

  8. Tsai YC, Tsai JC, Chiu YW, Kuo HT, Chen SC, Hwang SJ, Chen TH, Kuo MC, Chen HC. Is fluid overload more important than diabetes in renal progression in late chronic kidney disease? PLoS One. 2013;8:e82566.

    PubMed Central  PubMed  Google Scholar 

  9. Voroneanu L, Cusai C, Hogas S, Ardeleanu S, Onofriescu M, Nistor I, Prisada O, Sascau R, Goldsmith D, Covic A. The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies. Int Urol Nephrol. 2010;42:789–97.

    PubMed  Google Scholar 

  10. Ferrario M, Moissl U, Garzotto F, Cruz DN, Clementi A, Brendolan A, Tetta C, Gatti E, Signorini MG, Cerutti S, Ronco C. Effects of fluid overload on heart rate variability in chronic kidney disease patients on hemodialysis. BMC Nephrol. 2014;15:26.

    PubMed Central  PubMed  Google Scholar 

  11. Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V. Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant. 2012;27:2404–10.

    PubMed  Google Scholar 

  12. Hung SC, Kuo KL, Peng CH, Wu CH, Lien YC, Wang YC, Tarng DC. Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease. Kidney Int. 2014;85:703–9.

    CAS  PubMed  Google Scholar 

  13. Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009;24:1574–9.

    PubMed Central  PubMed  Google Scholar 

  14. Tsai YC, Tsai JC, Chen SC, Chiu YW, Hwang SJ, Hung CC, Chen TH, Kuo MC, Chen HC. Association of fluid overload with kidney disease progression in advanced ckd: a prospective cohort study. Am J Kidney Dis. 2014;63:68–75.

    PubMed  Google Scholar 

  15. Peter S, Pang PL. Pathophysiology of volume overload in acute heart failure syndromes. CME. 2010;16(Suppl 1):S1–6.

    Google Scholar 

  16. Kumar S, Berl T. Diseases of water metabolism. In: Schrier RW, editor. Atlas of diseases of the kidney. Wiley-Blackwell; 1999;1:1–19.

    Google Scholar 

  17. Sterns RH, Silver SM. Salt and water: read the package insert. QJM. 2003;96(8):549–52.

    Google Scholar 

  18. Jameson J, Loscalzo J. Harrison’s nephrology and acid-base disorders. New York: McGraw-Hill; 2010. 310. ISBN 978-0-07166339-7.

    Google Scholar 

  19. Bogum J, Faust D, Zuhlke K, Eichhorst J, Moutty MC, Furkert J, Eldahshan A, Neuenschwander M, von Kries JP, Wiesner B, Trimpert C, Deen PM, Valenti G, Rosenthal W, Klussmann E. Small-molecule screening identifies modulators of aquaporin-2 trafficking. J Am Soc Nephrol. 2013;24:744–58.

    CAS  PubMed Central  PubMed  Google Scholar 

  20. Titze J. Interstitial fluid homeostasis and pressure: news from the black box. Kidney Int. 2013;84:869–71.

    PubMed  Google Scholar 

  21. Ebah LM, Wiig H, Dawidowska I, O’Toole C, Summers A, Nikam M, Jayanti A, Coupes B, Brenchley P, Mitra S. Subcutaneous interstitial pressure and volume characteristics in renal impairment associated with edema. Kidney Int. 2013;84:980–8.

    PubMed  Google Scholar 

  22. Guyton AC. Interstitial fluid presure. ii. Pressure-volume curves of interstitial space. Circ Res. 1965;16:452–60.

    CAS  PubMed  Google Scholar 

  23. Titze J, Dahlmann A, Lerchl K, Kopp C, Rakova N, Schroder A, Luft FC. Spooky sodium balance. Kidney Int. 2014;85:759–67.

    CAS  PubMed  Google Scholar 

  24. Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol. 2000;278:F585–95.

    CAS  PubMed  Google Scholar 

  25. Kopp C, Linz P, Wachsmuth L, Dahlmann A, Horbach T, Schofl C, Renz W, Santoro D, Niendorf T, Muller DN, Neininger M, Cavallaro A, Eckardt KU, Schmieder RE, Luft FC, Uder M, Titze J. (23)na magnetic resonance imaging of tissue sodium. Hypertension. 2012;59:167–72.

    CAS  PubMed  Google Scholar 

  26. Kopp C, Linz P, Dahlmann A, Hammon M, Jantsch J, Muller DN, Schmieder RE, Cavallaro A, Eckardt KU, Uder M, Luft FC, Titze J. 23na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension. 2013;61:635–40.

    CAS  PubMed  Google Scholar 

  27. Rakova N, Juttner K, Dahlmann A, Schroder A, Linz P, Kopp C, Rauh M, Goller U, Beck L, Agureev A, Vassilieva G, Lenkova L, Johannes B, Wabel P, Moissl U, Vienken J, Gerzer R, Eckardt KU, Muller DN, Kirsch K, Morukov B, Luft FC, Titze J. Long-term space flight simulation reveals infradian rhythmicity in human na(+) balance. Cell Metab. 2013;17:125–31.

    CAS  PubMed  Google Scholar 

  28. Fridman AI, Matveev SA, Agalakova NI, Fedorova OV, Lakatta EG, Bagrov AY. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity. J Hypertens. 2002;20:1189–94.

    CAS  PubMed  Google Scholar 

  29. Rossi G, Manunta P, Hamlyn JM, Pavan E, De Toni R, Semplicini A, Pessina AC. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J Hypertens. 1995;13:1181–91.

    CAS  PubMed  Google Scholar 

  30. Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride–dependent hypertension. Circulation. 2002;105:1122–7.

    CAS  PubMed  Google Scholar 

  31. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB, Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY, Shapiro JI. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension. 2006;47:488–95.

    CAS  PubMed  Google Scholar 

  32. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens. 1999;17:1179–87.

    CAS  PubMed  Google Scholar 

  33. Yatime L, Laursen M, Morth JP, Esmann M, Nissen P, Fedosova NU. Structural insights into the high affinity binding of cardiotonic steroids to the na+, k + −atpase. J Struct Biol. 2011;174:296–306.

    CAS  PubMed  Google Scholar 

  34. Bagrov AY, Shapiro JI, Fedorova OV. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev. 2009;61:9–38.

    CAS  PubMed Central  PubMed  Google Scholar 

  35. Tian J, Haller S, Periyasamy S, Brewster P, Zhang H, Adlakha S, Fedorova OV, Xie ZJ, Bagrov AY, Shapiro JI, Cooper CJ. Renal ischemia regulates marinobufagenin release in humans. Hypertension. 2010;56:914–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  36. Tian J, Shidyak A, Periyasamy SM, Haller S, Taleb M, El-Okdi N, Elkareh J, Gupta S, Gohara S, Fedorova OV, Cooper CJ, Xie Z, Malhotra D, Bagrov AY, Shapiro JI. Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin. Hypertension. 2009;54:1313–20.

    CAS  PubMed Central  PubMed  Google Scholar 

  37. Skou JC. The influence of some cations on an adenosine triphosphatase from peripheral nerves. J Am Soc Nephrol. 1998;9:2170–7.

    CAS  PubMed  Google Scholar 

  38. Kaplan JH. Biochemistry of na, k-atpase. Annu Rev Biochem. 2002;71:511–35.

    CAS  PubMed  Google Scholar 

  39. Xie Z. Molecular mechanisms of na/k-atpase-mediated signal transduction. Ann N Y Acad Sci. 2003;986:497–503.

    CAS  PubMed  Google Scholar 

  40. Xie Z, Askari A. Na(+)/k(+)-atpase as a signal transducer. Eur J Biochem. 2002;269:2434–9.

    CAS  PubMed  Google Scholar 

  41. Xie Z, Cai T. Na + −k + −−atpase-mediated signal transduction: from protein interaction to cellular function. Mol Interv. 2003;3:157–68.

    CAS  PubMed  Google Scholar 

  42. Liu J, Liang M, Liu L, Malhotra D, Xie Z, Shapiro JI. Ouabain-induced endocytosis of the plasmalemmal na/k-atpase in llc-pk1 cells requires caveolin-1. Kidney Int. 2005;67:1844–54.

    CAS  PubMed  Google Scholar 

  43. Kolmakova EV, Haller ST, Kennedy DJ, Isachkina AN, Budny GV, Frolova EV, Piecha G, Nikitina ER, Malhotra D, Fedorova OV, Shapiro JI, Bagrov AY. Endogenous cardiotonic steroids in chronic renal failure. Nephrol Dial Transplant. 2011;26:2912–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  44. Haller ST, Kennedy DJ, Shidyak A, Budny GV, Malhotra D, Fedorova OV, Shapiro JI, Bagrov AY. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. Am J Hypertens. 2012;25:690–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  45. Elkareh J, Periyasamy SM, Shidyak A, Vetteth S, Schroeder J, Raju V, Hariri IM, El-Okdi N, Gupta S, Fedorova L, Liu J, Fedorova OV, Kahaleh MB, Xie Z, Malhotra D, Watson DK, Bagrov AY, Shapiro JI. Marinobufagenin induces increases in procollagen expression in a process involving protein kinase c and fli-1: implications for uremic cardiomyopathy. Am J Physiol Renal Physiol. 2009;296:F1219–26.

    CAS  PubMed Central  PubMed  Google Scholar 

  46. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003;42:864–81.

    PubMed  Google Scholar 

  47. Kopple JD. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J. 1997;43:246–50.

    CAS  PubMed  Google Scholar 

  48. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999;56:1136–48.

    CAS  PubMed  Google Scholar 

  49. Kalantar-Zadeh K, Stenvinkel P, Pillon L, Kopple JD. Inflammation and nutrition in renal insufficiency. Adv Ren Replace Ther. 2003;10:155–69.

    PubMed  Google Scholar 

  50. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimburger O, Cederholm T, Girndt M. Il-10, il-6, and tnf-alpha: central factors in the altered cytokine network of uremia–the good, the bad, and the ugly. Kidney Int. 2005;67:1216–33.

    CAS  PubMed  Google Scholar 

  51. Stenvinkel P, Lindholm B. C-reactive protein in end-stage renal disease: are there reasons to measure it? Blood Purif. 2005;23:72–8.

    CAS  PubMed  Google Scholar 

  52. Yao Q, Axelsson J, Stenvinkel P, Lindholm B. Chronic systemic inflammation in dialysis patients: an update on causes and consequences. ASAIO J. 2004;50:lii–lvii.

    PubMed  Google Scholar 

  53. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, Hoeks AP, van Kreel B, Gladziwa U, van der Sande FM, Leunissen KM. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int. 2002;22:477–87.

    PubMed  Google Scholar 

  54. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–911.

    CAS  PubMed  Google Scholar 

  55. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–9.

    PubMed  Google Scholar 

  56. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ademex, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13:1307–20.

    CAS  PubMed  Google Scholar 

  57. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–48.

    CAS  PubMed  Google Scholar 

  58. Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: what is next? Semin Dial. 2005;18:365–9.

    PubMed  Google Scholar 

  59. Demirci MS, Demirci C, Ozdogan O, Kircelli F, Akcicek F, Basci A, Ok E, Ozkahya M. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial Transplant. 2011;26:1708–16.

    PubMed  Google Scholar 

  60. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (solvd). J Am Coll Cardiol. 1996;27:1201–6.

    CAS  PubMed  Google Scholar 

  61. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res. 1997;81:187–95.

    CAS  PubMed  Google Scholar 

  62. Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 2000;35:537–44.

    CAS  PubMed  Google Scholar 

  63. Goncalves S, Pecoits-Filho R, Perreto S, Barberato SH, Stinghen AE, Lima EG, Fuerbringer R, Sauthier SM, Riella MC. Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant. 2006;21:2788–94.

    CAS  PubMed  Google Scholar 

  64. McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:133–41.

    CAS  PubMed Central  PubMed  Google Scholar 

  65. Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ, Port FK. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the dopps. Kidney Int. 2003;64:254–62.

    PubMed  Google Scholar 

  66. Jaeger JQ, Mehta RL. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol. 1999;10:392–403.

    CAS  PubMed  Google Scholar 

  67. Kooman JP, van der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms. Blood Purif. 2004;22:55–9.

    CAS  PubMed  Google Scholar 

  68. Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 2007;11:21–31.

    PubMed  Google Scholar 

  69. Levin NW, Zhu F, Keen M. Interdialytic weight gain and dry weight. Blood Purif. 2001;19:217–21.

    CAS  PubMed  Google Scholar 

  70. Vasko R, Muller GA, Ratliff BB, Jung K, Gauczinski S, Koziolek MJ. Clinical judgment is the most important element in overhydration assessment of chronic hemodialysis patients. Clin Exp Nephrol. 2013;17:563–8.

    PubMed Central  PubMed  Google Scholar 

  71. Lisowska A, Musial WJ. Heart failure in patients with chronic kidney disease. Rocz Akad Med Bialym (1995). 2004;49:162–5.

    CAS  Google Scholar 

  72. Hayashi SY, Rohani M, Lindholm B, Brodin LA, Lind B, Barany P, Alvestrand A, Seeberger A. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue doppler velocity imaging. Nephrol Dial Transplant. 2006;21:125–32.

    PubMed  Google Scholar 

  73. Agarwal R, Bouldin JM, Light RP, Garg A. Inferior vena cava diameter and left atrial diameter measure volume but not dry weight. Clin J Am Soc Nephrol. 2011;6:1066–72.

    PubMed Central  PubMed  Google Scholar 

  74. Katzarski KS, Nisell J, Randmaa I, Danielsson A, Freyschuss U, Bergstrom J. A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients. Am J Kidney Dis. 1997;30:459–65.

    CAS  PubMed  Google Scholar 

  75. Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med. 2004;351:1097–105.

    CAS  PubMed  Google Scholar 

  76. Cheriex EC, Leunissen KM, Janssen JH, Mooy JM, van Hooff JP. Echography of the inferior vena cava is a simple and reliable tool for estimation of ‘dry weight’ in haemodialysis patients. Nephrol Dial Transplant. 1989;4:563–8.

    CAS  PubMed  Google Scholar 

  77. McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrant P, Dargie HJ. Nt-probnp and the diagnosis of heart failure: a pooled analysis of three european epidemiological studies. Eur J Heart Fail. 2004;6:269–73.

    CAS  PubMed  Google Scholar 

  78. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does b-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625.

    CAS  PubMed Central  PubMed  Google Scholar 

  79. Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, Lamb EJ. B-type natriuretic peptide (bnp) and amino-terminal probnp in patients with ckd: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis. 2005;46:610–20.

    CAS  PubMed  Google Scholar 

  80. Mark PB, Stewart GA, Gansevoort RT, Petrie CJ, McDonagh TA, Dargie HJ, Rodger RS, Jardine AG. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Transplant. 2006;21:402–10.

    CAS  PubMed  Google Scholar 

  81. Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (bnp) and n-terminal pro-bnp. Hypertension. 2005;46:118–23.

    CAS  PubMed  Google Scholar 

  82. Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int. 2007;71:548–54.

    CAS  PubMed  Google Scholar 

  83. Racek J, Kralova H, Trefil L, Rajdl D, Eiselt J. Brain natriuretic peptide and n-terminal probnp in chronic haemodialysis patients. Nephron Clin Pract. 2006;103:c162–72.

    CAS  PubMed  Google Scholar 

  84. DeFilippi CR, Fink JC, Nass CM, Chen H, Christenson R. N-terminal pro-b-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic ckd not requiring dialysis. Am J Kidney Dis. 2005;46:35–44.

    CAS  PubMed  Google Scholar 

  85. Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR. N-terminal pro-b-type natriuretic peptide and b-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol. 2006;97:1530–4.

    CAS  PubMed  Google Scholar 

  86. Goto T, Takase H, Toriyama T, Sugiura T, Kurita Y, Tsuru N, Masuda H, Hayashi K, Ueda R, Dohi Y. Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron. 2002;92:610–5.

    CAS  PubMed  Google Scholar 

  87. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ. Raised plasma n-terminal pro-b-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease. Heart. 2006;92:1518–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  88. Rutten JH, Korevaar JC, Boeschoten EW, Dekker FW, Krediet RT, Boomsma F, van den Meiracker AH. B-type natriuretic peptide and amino-terminal atrial natriuretic peptide predict survival in peritoneal dialysis. Perit Dial Int. 2006;26:598–602.

    PubMed  Google Scholar 

  89. Westenbrink BD, Hovinga TK, Kloppenburg WD, Veeger NJ, Janssen WM. B-type natriuretic peptide and interdialytic fluid retention are independent and incremental predictors of mortality in hemodialysis patients. Clin Nephrol. 2011;76:373–9.

    CAS  PubMed  Google Scholar 

  90. Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 2006;26:360–5.

    CAS  PubMed  Google Scholar 

  91. David S, Kumpers P, Seidler V, Biertz F, Haller H, Fliser D. Diagnostic value of n-terminal pro-b-type natriuretic peptide (nt-probnp) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dial Transplant. 2008;23:1370–7.

    CAS  PubMed  Google Scholar 

  92. Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, Zeier M. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest. 2007;37:350–6.

    CAS  PubMed  Google Scholar 

  93. Antlanger M, Hecking M, Haidinger M, Werzowa J, Kovarik JJ, Paul G, Eigner M, Bonderman D, Horl WH, Saemann MD. Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status. BMC Nephrol. 2013;14:266.

    PubMed  Google Scholar 

  94. Jacobs LH, van de Kerkhof JJ, Mingels AM, Passos VL, Kleijnen VW, Mazairac AH, van der Sande FM, Wodzig WK, Konings CJ, Leunissen KM, van Dieijen-Visser MP, Kooman JP. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. Nephrol Dial Transplant. 2010;25:243–8.

    CAS  PubMed  Google Scholar 

  95. Mueller C, Laule-Kilian K, Scholer A, Nusbaumer C, Zeller T, Staub D, Perruchoud AP. B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison. Kidney Int. 2005;67:278–84.

    CAS  PubMed  Google Scholar 

  96. Booth J, Pinney J, Davenport A. N-terminal probnp–marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol. 2010;5:1036–40.

    CAS  PubMed Central  PubMed  Google Scholar 

  97. Fagugli RM, Palumbo B, Ricciardi D, Pasini P, Santirosi P, Vecchi L, Pasticci F, Palumbo R. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract. 2003;95:c60–6.

    CAS  PubMed  Google Scholar 

  98. Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis. 2003;41:1257–66.

    CAS  PubMed  Google Scholar 

  99. Davenport A. Changes in n-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients. Am J Nephrol. 2012;36:371–6.

    CAS  PubMed  Google Scholar 

  100. Chazot C, Vo-Van C, Zaoui E, Vanel T, Hurot JM, Lorriaux C, Mayor B, Deleaval P, Jean G. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. Nephrol Dial Transplant. 2011;26:2630–4.

    CAS  PubMed  Google Scholar 

  101. Breidthardt T, Kalbermatter S, Socrates T, Noveanu M, Klima T, Mebazaa A, Mueller C, Kiss D. Increasing b-type natriuretic peptide levels predict mortality in unselected haemodialysis patients. Eur J Heart Fail. 2011;13:860–7.

    CAS  PubMed  Google Scholar 

  102. Hecking M, Karaboyas A, Antlanger M, Saran R, Wizemann V, Chazot C, Rayner H, Horl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Moissl U, Kotanko P, Levin NW, Saemann MD, Kalantar-Zadeh K, Port FK, Wabel P. Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol. 2013;38:78–90.

    PubMed  Google Scholar 

  103. Kotanko P, Levin NW, Zhu F. Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant. 2008;23:808–12.

    PubMed  Google Scholar 

  104. Davenport A. Does bioimpedance analysis or measurement of natriuretic peptides aid volume assessment in peritoneal dialysis patients? Adv Perit Dial. 2013;29:64–8.

    PubMed  Google Scholar 

  105. Abbas SR, Liu L, Sipahioglu MH, Rosales L, Carter M, Kotanko P, Levin NW, Zhu F. Comparison of bioimpedance techniques to detect changes in fluid status in hemodialysis patients. Blood Purif. 2014;37:48–56.

    PubMed  Google Scholar 

  106. Moissl U, Arias-Guillen M, Wabel P, Fontsere N, Carrera M, Campistol JM, Maduell F. Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8:1575–82.

    PubMed Central  PubMed  Google Scholar 

  107. Raimann JG, Zhu F, Wang J, Thijssen S, Kuhlmann MK, Kotanko P, Levin NW, Kaysen GA. Comparison of fluid volume estimates in chronic hemodialysis patients by bioimpedance, direct isotopic, and dilution methods. Kidney Int. 2014;85:898–908.

    PubMed  Google Scholar 

  108. Verdalles U, de Vinuesa SG, Goicoechea M, Quiroga B, Reque J, Panizo N, Arroyo D, Luno J. Utility of bioimpedance spectroscopy (bis) in the management of refractory hypertension in patients with chronic kidney disease (ckd). Nephrol Dial Transplant. 2012;27 Suppl 4:iv31–5.

    PubMed  Google Scholar 

  109. Onofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay M, Covic AC. Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis. 2014;64(1):111–8.

    PubMed  Google Scholar 

  110. Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, Taborsky P, Tetta C, Velasco N, Vlasak J, Zaluska W, Wizemann V. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008;23:2965–71.

    PubMed  Google Scholar 

  111. Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013;61:957–65.

    PubMed  Google Scholar 

  112. Machek P, Jirka T, Moissl U, Chamney P, Wabel P. Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant. 2010;25:538–44.

    PubMed Central  PubMed  Google Scholar 

  113. Odudu A, McIntyre C. Volume is not the only key to hypertension control in hemodialysis patients. Nephron Clin Pract. 2012;120(3):c173–7.

    CAS  PubMed  Google Scholar 

  114. Chen W, Guo LJ, Wang T. Extracellular water/intracellular water is a strong predictor of patient survival in incident peritoneal dialysis patients. Blood Purif. 2007;25:260–6.

    PubMed  Google Scholar 

  115. Nalesso F, Ferrario M, Moissl U, Brendolan A, Zanella M, Cruz DN, Basso F, Floris M, Clementi A, Garzotto F, Tetta C, Signorini MG, Cerrutti S, Ronco C. Body composition and heart rate variability to achieve dry weight and tolerance. Contrib Nephrol. 2011;171:181–6.

    CAS  PubMed  Google Scholar 

  116. Wabel P, Chamney P, Moissl U, Jirka T. Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif. 2009;27:75–80.

    PubMed Central  PubMed  Google Scholar 

  117. Covic A, Onofriescu M. Time to improve fluid management in hemodialysis: should we abandon clinical assessment and routinely use bioimpedance? Clin J Am Soc Nephrol. 2013;8:1474–5.

    PubMed Central  PubMed  Google Scholar 

  118. Zhu F, Leonard EF, Levin NW. Extracellular fluid redistribution during hemodialysis: bioimpedance measurement and model. Physiol Meas. 2008;29:S491–501.

    PubMed  Google Scholar 

  119. Seibert E, Zhu F, Kuhlmann MK, Henson R, Oribello AM, Girndt M, Kotanko P, Levin NW. Slope analysis of blood volume and calf bioimpedance monitoring in hemodialysis patients. Nephrol Dial Transplant. 2012;27:4430–6.

    PubMed  Google Scholar 

  120. Liu L, Zhu F, GR J, Thijssen S, Sipahioglu MH, Wystrychowski G, Kitzler T, Tetta C, Wabel P, Kotanko P, Levin NW. Determination of fluid status in haemodialysis patients with whole body and calf bioimpedance techniques. Nephrology (Carlton). 2012;17:131–40.

    Google Scholar 

  121. Liu L, Long G, Ren J, Li J, Xu J, Lei J, Li M, Qiu M, Yuan P, Sun W, Lin S, Liu W, Sun Y, Ma Y, Mao Y, Shen Y, Zuo L. A randomized controlled trial of long term effect of bcm guided fluid management in mhd patients (bocomo study): rationales and study design. BMC Nephrol. 2012;13:120.

    PubMed Central  PubMed  Google Scholar 

  122. Dasselaar JJ, Huisman RM, de Jong PE, Franssen CF. Measurement of relative blood volume changes during haemodialysis: merits and limitations. Nephrol Dial Transplant. 2005;20:2043–9.

    PubMed  Google Scholar 

  123. Barth C, Boer W, Garzoni D, Kuenzi T, Ries W, Schaefer R, Schneditz D, Tsobanelis T, van der Sande F, Wojke R, Schilling H, Passlick-Deetjen J. Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume? Nephrol Dial Transplant. 2003;18:1353–60.

    PubMed  Google Scholar 

  124. Candan C, Sever L, Civilibal M, Caliskan S, Arisoy N. Blood volume monitoring to adjust dry weight in hypertensive pediatric hemodialysis patients. Pediatr Nephrol. 2009;24:581–7.

    PubMed  Google Scholar 

  125. Steuer RR, Leypoldt JK, Cheung AK, Harris DH, Conis JM. Hematocrit as an indicator of blood volume and a predictor of intradialytic morbid events. ASAIO J. 1994;40:M691–6.

    CAS  PubMed  Google Scholar 

  126. Basile C, Giordano R, Vernaglione L, Montanaro A, De Maio P, De Padova F, Marangi AL, Di Marco L, Santese D, Semeraro A, Ligorio VA. Efficacy and safety of haemodialysis treatment with the hemocontrol biofeedback system: a prospective medium-term study. Nephrol Dial Transplant. 2001;16:328–34.

    CAS  PubMed  Google Scholar 

  127. Wolkotte C, Hassell DR, Moret K, Gerlag PG, van den Wall Bake AW, van der Sande FM, Kooman JP. Blood volume control by biofeedback and dialysis-induced symptomatology. A short-term clinical study. Nephron. 2002;92:605–9.

    PubMed  Google Scholar 

  128. Rodriguez HJ, Domenici R, Diroll A, Goykhman I. Assessment of dry weight by monitoring changes in blood volume during hemodialysis using crit-line. Kidney Int. 2005;68:854–61.

    PubMed  Google Scholar 

  129. Lopot F, Kotyk P, Blaha J, Forejt J. Use of continuous blood volume monitoring to detect inadequately high dry weight. Int J Artif Organs. 1996;19:411–4.

    CAS  PubMed  Google Scholar 

  130. Sinha AD, Light RP, Agarwal R. Relative plasma volume monitoring during hemodialysis aids the assessment of dry weight. Hypertension. 2010;55:305–11.

    CAS  PubMed Central  PubMed  Google Scholar 

  131. Zoccali C, Torino C, Tripepi R, Tripepi G, D’Arrigo G, Postorino M, Gargani L, Sicari R, Picano E, Mallamaci F. Pulmonary congestion predicts cardiac events and mortality in esrd. J Am Soc Nephrol. 2013;24:639–46.

    PubMed Central  PubMed  Google Scholar 

  132. Reddan DN, Szczech LA, Hasselblad V, Lowrie EG, Lindsay RM, Himmelfarb J, Toto RD, Stivelman J, Winchester JF, Zillman LA, Califf RM, Owen Jr WF. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol. 2005;16:2162–9.

    PubMed  Google Scholar 

  133. Hecking M, Antlanger M, Winnicki W, Reiter T, Werzowa J, Haidinger M, Weichhart T, Polaschegg HD, Josten P, Exner I, Lorenz-Turnheim K, Eigner M, Paul G, Klauser-Braun R, Horl WH, Sunder-Plassmann G, Saemann MD. Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial. Trials. 2012;13:79.

    PubMed Central  PubMed  Google Scholar 

  134. Lichtenstein D. General ultrasound in the critically ill. New York: Springer; 2004.

    Google Scholar 

  135. Volpicelli G, Mussa A, Garofalo G, Cardinale L, Casoli G, Perotto F, Fava C, Frascisco M. Bedside lung ultrasound in the assessment of alveolar-interstitial syndrome. Am J Emerg Med. 2006;24:689–96.

    PubMed  Google Scholar 

  136. Agricola E, Bove T, Oppizzi M, Marino G, Zangrillo A, Margonato A, Picano E. “Ultrasound comet-tail images”: a marker of pulmonary edema: a comparative study with wedge pressure and extravascular lung water. Chest. 2005;127:1690–5.

    PubMed  Google Scholar 

  137. Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E. Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail. 2008;10:70–7.

    CAS  PubMed  Google Scholar 

  138. Frassi F, Gargani L, Gligorova S, Ciampi Q, Mottola G, Picano E. Clinical and echocardiographic determinants of ultrasound lung comets. Eur J Echocardiogr. 2007;8:474–9.

    PubMed  Google Scholar 

  139. McGee WT, Mailloux P, Jodka P, Thomas J. The pulmonary artery catheter in critical care. Semin Dial. 2006;19:480–91.

    PubMed  Google Scholar 

  140. Picano E, Gargani L, Gheorghiade M. Why, when, and how to assess pulmonary congestion in heart failure: pathophysiological, clinical, and methodological implications. Heart Fail Rev. 2010;15:63–72.

    PubMed  Google Scholar 

  141. Lichtenstein DA, Meziere GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the blue protocol. Chest. 2008;134:117–25.

    PubMed Central  PubMed  Google Scholar 

  142. Noble VE, Murray AF, Capp R, Sylvia-Reardon MH, Steele DJ, Liteplo A. Ultrasound assessment for extravascular lung water in patients undergoing hemodialysis. Time course for resolution. Chest. 2009;135:1433–9.

    PubMed  Google Scholar 

  143. Lichtenstein D, Meziere G. A lung ultrasound sign allowing bedside distinction between pulmonary edema and copd: the comet-tail artifact. Intensive Care Med. 1998;24:1331–4.

    CAS  PubMed  Google Scholar 

  144. Mallamaci F, Benedetto FA, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C. Detection of pulmonary congestion by chest ultrasound in dialysis patients. JACC Cardiovasc Imaging. 2010;3:586–94.

    PubMed  Google Scholar 

  145. Siriopol D, Hogas S, Voroneanu L, Onofriescu M, Apetrii M, Oleniuc M, Moscalu M, Sascau R, Covic A. Predicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters. Nephrol Dial Transplant. 2013;28:2851–9.

    PubMed  Google Scholar 

  146. ERA-EDTA Lung Water by Ultra-Sound Guided Treatment to Prevent Death and Cardiovascular Complications in High Risk End Stage Renal Disease (ESRD) Patients with Cardiomyopathy. http://www.era-edta.org/eureca-m/LUST_eureca-m.html.

  147. Extravascular Lung Water Monitoring by Combined Ultrasound and Bioimpedance as a Guide for Treatment in Hemodialysis Patients. http://clinicaltrials.gov/show/NCT01815762.

  148. Sipahioglu MH, Kocyigit I, Unal A, Karakurt M, Celik A, Tokgoz B, Oymak O, Utas C. Effect of serum electrolyte and bicarbonate concentration changes during hemodialysis sessions on heart rate variability. J Nephrol. 2012;25:1067–74.

    CAS  PubMed  Google Scholar 

  149. Chan CT. Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death? Nephrol Dial Transplant. 2008;23:3061–2.

    PubMed  Google Scholar 

  150. Kleiger RE, Bigger JT, Bosner MS, Chung MK, Cook JR, Rolnitzky LM, Steinman R, Fleiss JL. Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol. 1991;68:626–30.

    CAS  PubMed  Google Scholar 

  151. Huikuri HV, Kessler KM, Terracall E, Castellanos A, Linnaluoto MK, Myerburg RJ. Reproducibility and circadian rhythm of heart rate variability in healthy subjects. Am J Cardiol. 1990;65:391–3.

    CAS  PubMed  Google Scholar 

  152. Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol. 1996;27:270–6.

    CAS  PubMed  Google Scholar 

  153. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565–70.

    PubMed  Google Scholar 

  154. Ligtenberg G, Blankestijn PJ, Koomans HA. Hemodynamic response during lower body negative pressure: role of volume status. J Am Soc Nephrol. 1998;9:105–13.

    CAS  PubMed  Google Scholar 

  155. Horner SM, Murphy CF, Coen B, Dick DJ, Harrison FG, Vespalcova Z, Lab MJ. Contribution to heart rate variability by mechanoelectric feedback. Stretch of the sinoatrial node reduces heart rate variability. Circulation. 1996;94:1762–7.

    CAS  PubMed  Google Scholar 

  156. Oikawa K, Ishihara R, Maeda T, Yamaguchi K, Koike A, Kawaguchi H, Tabata Y, Murotani N, Itoh H. Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol. 2009;131:370–7.

    PubMed  Google Scholar 

  157. Basso F, Milan Manani S, Cruz DN, Teixeira C, Brendolan A, Nalesso F, Zanella M, Ronco C. Comparison and reproducibility of techniques for fluid status assessment in chronic hemodialysis patients. Cardiorenal Med. 2013;3:104–12.

    CAS  PubMed Central  PubMed  Google Scholar 

  158. Herzog CA, Asinger RW, Berger AK, Charytan DM, Diez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E. Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (kdigo). Kidney Int. 2011;80:572–86.

    PubMed  Google Scholar 

  159. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382:339–52.

    PubMed  Google Scholar 

  160. Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, Jindal K, Quinn R, Culleton BF, Wiebe N, Krause R, Thorlacius L, Tonelli M. Overview of the alberta kidney disease network. BMC Nephrol. 2009;10:30.

    PubMed Central  PubMed  Google Scholar 

  161. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371:2173–82.

    PubMed  Google Scholar 

  162. Henriquez-Palop F, Anton-Perez G, Marrero-Robayna S, Gonzalez-Cabrera F, Rodriguez-Perez JC. Water overload as a biomarker for heart failure and acute renal failure. Nefrologia. 2013;33:256–65.

    PubMed  Google Scholar 

  163. Chen HH, Schrier RW. Pathophysiology of volume overload in acute heart failure syndromes. Am J Med. 2006;119:S11–6.

    CAS  PubMed  Google Scholar 

  164. Yee-Moon Wang A, Lu Y, Cheung S, Hiu-Shuen Chan I, Wai-Kei Lam C. Plasma sodium and subclinical left atrial enlargement in chronic kidney disease. Nephrol Dial Transplant. 2013;28:2319–28.

    PubMed  Google Scholar 

  165. Mallamaci F, Tripepi G. Salt and the heart in chronic kidney disease: an atrial connection. Nephrol Dial Transplant. 2013;28:2210–1.

    PubMed  Google Scholar 

  166. Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JA, Lewis JL, Rocco MV. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002;61:266–75.

    PubMed  Google Scholar 

  167. Inal S, Erten Y, Okyay GU, Ataş N, Oneç K, Yayla C, Tekbudak MY, Sahin G, Tavil Y, Sindel S. Association between bioimpedance analysis parameters and left ventricular hypertrophy inperitoneal dialysis patients. Int Urol Nephrol. 2014;46(9):1851–6.

    Google Scholar 

  168. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H. Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant. 2002;17:1713–24.

    PubMed  Google Scholar 

  169. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F. Cardiac and arterial intercations in end-stage renal disease. Kidney Int. 1996;50(2):600–8.

    CAS  PubMed  Google Scholar 

  170. Gusbeth-Tatomir P, Covic A. Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res. 2007;30:97–107.

    PubMed  Google Scholar 

  171. Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in united states hemodialysis patients: Usrds waves 3 and 4 study. Kidney Int. 2002;62:1784–90.

    PubMed  Google Scholar 

  172. Guerin AP, Pannier B, Metivier F, Marchais SJ, London GM. Assessment and significance of arterial stiffness in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:635–41.

    PubMed  Google Scholar 

  173. Meeus F, Kourilsky O, Guerin AP, Gaudry C, Marchais SJ, London GM. Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int Suppl. 2000;76:S140–7.

    CAS  PubMed  Google Scholar 

  174. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932–43.

    CAS  PubMed  Google Scholar 

  175. Kanbay M, Afsar B, Gusbeth-Tatomir P, Covic A. Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol. 2010;42:741–52.

    PubMed  Google Scholar 

  176. Ie EH, De Backer TL, Carlier SG, Vletter WB, Nette RW, Weimar W, Zietse R. Ultrafiltration improves aortic compliance in haemodialysis patients. J Hum Hypertens. 2005;19:439–44.

    CAS  PubMed  Google Scholar 

  177. Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA. Contribution of volume overload and angiotensin ii to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol. 2002;13:177–83.

    CAS  PubMed  Google Scholar 

  178. Hogas S, Ardeleanu S, Segall L, Serban DN, Serban IL, Hogas M, Apetrii M, Onofriescu M, Sascau R, Covic A. Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function. Int Urol Nephrol. 2012;44:897–905.

    CAS  PubMed  Google Scholar 

  179. Georgianos PI, Sarafidis PA, Karpetas A, Kosmidis D, Sioulis A, Liakopoulos V, Stamatiadis DN, Papagianni A, Zebekakis PE, Nikolaidis P, Lasaridis AN. Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures. Blood Purif. 2014;37:18–26.

    PubMed  Google Scholar 

  180. Zoccali C, Mallamaci F, Tripepi G. Sleep apnea in renal patients. J Am Soc Nephrol. 2001;12:2854–9.

    CAS  PubMed  Google Scholar 

  181. Zoccali C, Mallamaci F, Tripepi G. Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J Am Soc Nephrol. 2002;13:729–33.

    PubMed  Google Scholar 

  182. Zoccali C, Benedetto FA, Tripepi G, Cambareri F, Panuccio V, Candela V, Mallamaci F, Enia G, Labate C, Tassone F. Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int. 1998;53:1078–84.

    CAS  PubMed  Google Scholar 

  183. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–5.

    CAS  PubMed  Google Scholar 

  184. Arzt M, Young T, Finn L, Skatrud JB, Ryan CM, Newton GE, Mak S, Parker JD, Floras JS, Bradley TD. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med. 2006;166:1716–22.

    PubMed  Google Scholar 

  185. Kimmel PL, Miller G, Mendelson WB. Sleep apnea syndrome in chronic renal disease. Am J Med. 1989;86:308–14.

    CAS  PubMed  Google Scholar 

  186. Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med. 2001;344:102–7.

    CAS  PubMed  Google Scholar 

  187. Tang SC, Lam B, Ku PP, Leung WS, Chu CM, Ho YW, Ip MS, Lai KN. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 2006;17:2607–16.

    PubMed  Google Scholar 

  188. Elias RM, Bradley TD, Kasai T, Motwani SS, Chan CT. Rostral overnight fluid shift in end-stage renal disease: relationship with obstructive sleep apnea. Nephrol Dial Transplant. 2012;27:1569–73.

    PubMed  Google Scholar 

  189. Elias RM, Chan CT, Paul N, Motwani SS, Kasai T, Gabriel JM, Spiller N, Bradley TD. Relationship of pharyngeal water content and jugular volume with severity of obstructive sleep apnea in renal failure. Nephrol Dial Transplant. 2013;28:937–44.

    CAS  PubMed  Google Scholar 

  190. Ozkahya M, Ok E, Toz H, Asci G, Duman S, Basci A, Kose T, Dorhout Mees EJ. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant. 2006;21:3506–13.

    PubMed  Google Scholar 

  191. Vaara ST, Korhonen AM, Kaukonen KM, Nisula S, Inkinen O, Hoppu S, Laurila JJ, Mildh L, Reinikainen M, Lund V, Parviainen I, Pettila V. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective finnaki study. Crit Care. 2012;16:R197.

    PubMed Central  PubMed  Google Scholar 

  192. O’Lone EL, Visser A, Finney H, Fan SL. Clinical significance of multi-frequency bioimpedance spectroscopy in peritoneal dialysis patients: independent predictor of patient survival. Nephrol Dial Transplant. 2014;29(7):1430–7.

    PubMed  Google Scholar 

  193. Covic A, Voroneanu L, Locatelli F. Uraemic toxins versus volume and water as the major factor that matters with dialysis. Nephrol Dial Transplant. 2012;27:58–62.

    PubMed  Google Scholar 

  194. Dorairajan S, Chockalingam A, Misra M. Myocardial stunning in hemodialysis: what is the overall message? Hemodial Int. 2010;14:447–50.

    PubMed  Google Scholar 

  195. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4:914–20.

    PubMed Central  PubMed  Google Scholar 

  196. Iseki K, Shoji T, Nakai S, Watanabe Y, Akiba T, Tsubakihara Y. Higher survival rates of chronic hemodialysis patients on anti-hypertensive drugs. Nephron Clin Pract. 2009;113:c183–90.

    CAS  PubMed  Google Scholar 

  197. Tisler A, Akocsi K, Borbas B, Fazakas L, Ferenczi S, Gorogh S, Kulcsar I, Nagy L, Samik J, Szegedi J, Toth E, Wagner G, Kiss I. The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dial Transplant. 2003;18:2601–5.

    PubMed  Google Scholar 

  198. Paniagua R, Ventura MD, Avila-Diaz M, Hinojosa-Heredia H, Mendez-Duran A, Cueto-Manzano A, Cisneros A, Ramos A, Madonia-Juseino C, Belio-Caro F, Garcia-Contreras F, Trinidad-Ramos P, Vazquez R, Ilabaca B, Alcantara G, Amato D. Nt-probnp, fluid volume overload and dialysis modality are independent predictors of mortality in esrd patients. Nephrol Dial Transplant. 2010;25:551–7.

    CAS  PubMed  Google Scholar 

  199. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt cooperative research group. BMJ. 1996;312:1249–53.

    CAS  PubMed Central  PubMed  Google Scholar 

  200. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith Jr SC, Vafiadis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the american heart association. Circulation. 2011;123:1138–43.

    PubMed  Google Scholar 

  201. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller 3rd ER, Simons-Morton DG, Karanja N, Lin PH. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet. Dash-sodium collaborative research group. N Engl J Med. 2001;344:3–10.

    CAS  PubMed  Google Scholar 

  202. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (tohp). BMJ. 2007;334:885–8.

    PubMed Central  PubMed  Google Scholar 

  203. Go AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, Sanchez E. American Heart Association; American College of Cardiology; Centers for Disease Control and Prevention. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014;63(4):878–85.

    Google Scholar 

  204. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54:475–81.

    CAS  PubMed Central  PubMed  Google Scholar 

  205. Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension. 2004;44:35–41.

    CAS  PubMed  Google Scholar 

  206. Tzemos N, Lim PO, Wong S, Struthers AD, MacDonald TM. Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension. 2008;51:1525–30.

    CAS  PubMed  Google Scholar 

  207. Dickinson KM, Keogh JB, Clifton PM. Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr. 2009;89:485–90.

    CAS  PubMed  Google Scholar 

  208. Jablonski KL, Gates PE, Pierce GL, Seals DR. Low dietary sodium intake is associated with enhanced vascular endothelial function in middle-aged and older adults with elevated systolic blood pressure. Ther Adv Cardiovasc Dis. 2009;3:347–56.

    PubMed Central  PubMed  Google Scholar 

  209. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (cochrane review). Am J Hypertens. 2011;24:843–53.

    CAS  PubMed  Google Scholar 

  210. O’Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306:2229–38.

    PubMed  Google Scholar 

  211. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Waden J, Tolonen N, Saraheimo M, Gordin D, Groop PH. The association between dietary sodium intake, esrd, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34:861–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  212. Ekinci EI, Clarke S, Thomas MC, Moran JL, Cheong K, MacIsaac RJ, Jerums G. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care. 2011;34:703–9.

    PubMed Central  PubMed  Google Scholar 

  213. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerova J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, Filipovsky J, Kawecka-Jaszcz K, Nikitin Y, Staessen JA. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305:1777–85.

    CAS  PubMed  Google Scholar 

  214. Suckling RJ, He FJ, Macgregor GA. Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev. 2010;(12):CD006763.

    Google Scholar 

  215. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19:999–1007.

    CAS  PubMed Central  PubMed  Google Scholar 

  216. Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, De Nicola L. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab. 1998;24:296–301.

    CAS  PubMed  Google Scholar 

  217. He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, MacGregor GA. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and asian mild hypertensives. Hypertension. 2009;54:482–8.

    CAS  PubMed  Google Scholar 

  218. Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ. 2011;343:d4366.

    PubMed Central  PubMed  Google Scholar 

  219. Krikken JA, Laverman GD, Navis G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hypertens. 2009;18:531–8.

    CAS  PubMed  Google Scholar 

  220. De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, Strippoli M, Casino F, Giannattasio M, Petrarulo F, Virgilio M, Laraia E, Di Iorio BR, Savica V, Conte G. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69:538–45.

    PubMed  Google Scholar 

  221. Kutlugun AA, Arici M, Yildirim T, Turgut D, Yilmaz R, Altindal M, Altun B, Erdem Y, Yasavul U, Turgan C. Daily sodium intake in chronic kidney disease patients during nephrology clinic follow-up: an observational study with 24-hour urine sodium measurement. Nephron Clin Pract. 2011;118:c361–6.

    PubMed  Google Scholar 

  222. Levin A, Stevens PE. Summary of kdigo 2012 ckd guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85:49–61.

    PubMed  Google Scholar 

  223. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Campbell KL. A randomized trial of dietary sodium restriction in ckd. J Am Soc Nephrol. 2013;24:2096–103.

    CAS  PubMed  Google Scholar 

  224. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Hale RE, Campbell KL. The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (lowsalt ckd study): protocol of a randomized trial. BMC Nephrol. 2012;13:137.

    PubMed Central  PubMed  Google Scholar 

  225. Leurs LJ, Schouten LJ, Goldbohm RA, van den Brandt PA. Total fluid and specific beverage intake and mortality due to ihd and stroke in the netherlands cohort study. Br J Nutr. 2010;104:1212–21.

    CAS  PubMed  Google Scholar 

  226. Chan J, Knutsen SF, Blix GG, Lee JW, Fraser GE. Water, other fluids, and fatal coronary heart disease: the adventist health study. Am J Epidemiol. 2002;155:827–33.

    PubMed  Google Scholar 

  227. Sontrop JM, Dixon SN, Garg AX, Buendia-Jimenez I, Dohein O, Huang SH, Clark WF. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of nhanes data. Am J Nephrol. 2013;37:434–42.

    PubMed  Google Scholar 

  228. Strippoli GF, Craig JC, Rochtchina E, Flood VM, Wang JJ, Mitchell P. Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton). 2011;16:326–34.

    Google Scholar 

  229. Palmer SC, Wong G, Iff S, Yang J, Jayaswal V, Craig JC, Rochtchina E, Mitchell P, Wang JJ, Strippoli GF. Fluid intake and all-cause mortality, cardiovascular mortality, and kidney function: a population-based longitudinal cohort study. Nephrol Dial Transplant. 2014;29(7):1377–84.

    PubMed  Google Scholar 

  230. Intakes. TNAPSCotSEoDR. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. http://books.nap.edu/openbook.php?record_id=10925&page=73. 2005.

  231. Komiya I, Yamada T, Takasu N, Asawa T, Akamine H, Yagi N, Nagasawa Y, Ohtsuka H, Miyahara Y, Sakai H, Sato A, Aizawa T. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system. J Hypertens. 1997;15:65–72.

    CAS  PubMed  Google Scholar 

  232. Wannamethee G, Whincup PH, Shaper AG, Lever AF. Serum sodium concentration and risk of stroke in middle-aged males. J Hypertens. 1994;12:971–9.

    CAS  PubMed  Google Scholar 

  233. Friedman SM, McIndoe RA, Tanaka M. The relation of blood sodium concentration to blood pressure in the rat. J Hypertens. 1990;8:61–6.

    CAS  PubMed  Google Scholar 

  234. Ozkahya M, Toz H, Qzerkan F, Duman S, Ok E, Basci A, Mees EJ. Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol. 2002;15:655–60.

    PubMed  Google Scholar 

  235. Marshall MR, Dunlop JL. Are dialysate sodium levels too high? Semin Dial. 2012;25:277–83.

    PubMed  Google Scholar 

  236. Chan CT, Covic A, Craig JC, Davenport A, Kasiske BL, Kuhlmann MK, Levin NW, Li PK, Locatelli F, Rocco MV, Wheeler DC. Novel techniques and innovation in blood purification: a clinical update from kidney disease: improving global outcomes. Kidney Int. 2013;83:359–71.

    PubMed  Google Scholar 

  237. Santos SF, Peixoto AJ. Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:522–30.

    CAS  PubMed  Google Scholar 

  238. Davenport A. Audit of the effect of dialysate sodium concentration on inter-dialytic weight gains and blood pressure control in chronic haemodialysis patients. Nephron Clin Pract. 2006;104:c120–5.

    PubMed  Google Scholar 

  239. Flanigan M. Dialysate composition and hemodialysis hypertension. Semin Dial. 2004;17:279–83.

    PubMed  Google Scholar 

  240. Dunlop JL, Vandal AC, de Zoysa JR, Gabriel RS, Haloob IA, Hood CJ, Matheson PJ, McGregor DO, Rabindranath KS, Semple DJ, Marshall MR. Rationale and design of the sodium lowering in dialysate (solid) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol. 2013;14:149.

    CAS  PubMed Central  PubMed  Google Scholar 

  241. Song JH, Park GH, Lee SY, Lee SW, Lee SW, Kim MJ. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol. 2005;16:237–46.

    PubMed  Google Scholar 

  242. Mann H, Stiller S. Sodium modelling. Kidney Int Suppl. 2000;76:S79–88.

    CAS  PubMed  Google Scholar 

  243. Song JH, Lee SW, Suh CK, Kim MJ. Time-averaged concentration of dialysate sodium relates with sodium load and interdialytic weight gain during sodium-profiling hemodialysis. Am J Kidney Dis. 2002;40:291–301.

    CAS  PubMed  Google Scholar 

  244. Hecking M, Karaboyas A, Saran R, Sen A, Inaba M, Rayner H, Horl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK. Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol. 2012;7:92–100.

    CAS  PubMed Central  PubMed  Google Scholar 

  245. Penne EL, Levin NW, Kotanko P. Improving volume status by comprehensive dietary and dialytic sodium management in chronic hemodialysis patients. Blood Purif. 2010;30:71–8.

    CAS  PubMed  Google Scholar 

  246. Raimann J, Liu L, Tyagi S, Levin NW, Kotanko P. A fresh look at dry weight. Hemodial Int. 2008;12:395–405.

    PubMed  Google Scholar 

  247. Keen ML, Gotch FA. The association of the sodium “setpoint” to interdialytic weight gain and blood pressure in hemodialysis patients. Int J Artif Organs. 2007;30:971–9.

    CAS  PubMed  Google Scholar 

  248. Peixoto AJ, Gowda N, Parikh CR, Santos SF. Long-term stability of serum sodium in hemodialysis patients. Blood Purif. 2010;29:264–7.

    CAS  PubMed  Google Scholar 

  249. Mc Causland FR, Brunelli SM, Waikar SS. Dialysate sodium, serum sodium and mortality in maintenance hemodialysis. Nephrol Dial Transplant. 2012;27:1613–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  250. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007;298:1291–9.

    CAS  PubMed  Google Scholar 

  251. Nigwekar SU, Wenger J, Thadhani R, Bhan I. Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study. Am J Kidney Dis. 2013;62(4):755–62.

    Google Scholar 

  252. Waikar SS, Curhan GC, Brunelli SM. Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med. 2011;124:77–84.

    CAS  PubMed Central  PubMed  Google Scholar 

  253. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012;125:677–84.

    PubMed Central  PubMed  Google Scholar 

  254. Arramreddy R, Sun SJ, Munoz Mendoza J, Chertow GM, Schiller B. Individualized reduction in dialysate sodium in conventional in-center hemodialysis. Hemodial Int. 2012;16:473–80.

    PubMed Central  PubMed  Google Scholar 

  255. Hecking M, Karaboyas A, Saran R, Sen A, Horl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the dialysis outcomes and practice patterns study (dopps). Am J Kidney Dis. 2012;59:238–48.

    CAS  PubMed  Google Scholar 

  256. de Paula FM, Peixoto AJ, Pinto LV, Dorigo D, Patricio PJ, Santos SF. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int. 2004;66:1232–8.

    PubMed  Google Scholar 

  257. Sayarlioglu H, Erkoc R, Tuncer M, Soyoral Y, Esen R, Gumrukcuoglu HA, Dogan E, Sayarlioglu M. Effects of low sodium dialysate in chronic hemodialysis patients: an echocardiographic study. Ren Fail. 2007;29:143–6.

    PubMed  Google Scholar 

  258. Aybal Kutlugun A, Erdem Y, Okutucu S, Yorgun H, Atalar E, Arici M. Effects of lowering dialysate sodium on flow-mediated dilatation in patients with chronic kidney disease. Nephrol Dial Transplant. 2011;26:3678–82.

    PubMed  Google Scholar 

  259. Thein H, Haloob I, Marshall MR. Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain. Nephrol Dial Transplant. 2007;22:2630–9.

    CAS  PubMed  Google Scholar 

  260. Charra B, Calemard E, Cuche M, Laurent G. Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron. 1983;33:96–9.

    CAS  PubMed  Google Scholar 

  261. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int. 1992;41:1286–91.

    CAS  PubMed  Google Scholar 

  262. Charra B, Chazot C, Jean G, Hurot JM, Vanel T, Terrat JC, VoVan C. Long 3 x 8 hr dialysis: a three-decade summary. J Nephrol. 2003;16 Suppl 7:S64–9.

    PubMed  Google Scholar 

  263. Kjellstrand CM, Buoncristiani U, Ting G, Traeger J, Piccoli GB, Sibai-Galland R, Young BA, Blagg CR. Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant. 2008;23:3283–9.

    PubMed  Google Scholar 

  264. Klarenbach S, Heidenheim AP, Leitch R, Lindsay RM. Reduced requirement for erythropoietin with quotidian hemodialysis therapy. ASAIO J. 2002;48:57–61.

    CAS  PubMed  Google Scholar 

  265. Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in the netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant. 1998;13:2853–60.

    CAS  PubMed  Google Scholar 

  266. Fagugli RM, Buoncristiani U, Ciao G. Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients. Int J Artif Organs. 1998;21:429–31.

    CAS  PubMed  Google Scholar 

  267. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis. 2001;38:371–6.

    CAS  PubMed  Google Scholar 

  268. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002;61:2235–9.

    PubMed  Google Scholar 

  269. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity esrd patients converted from conventional to short daily hemodialysis. Am J Kidney Dis. 2003;42:1020–35.

    PubMed  Google Scholar 

  270. Rao M, Muirhead N, Klarenbach S, Moist L, Lindsay RM. Management of anemia with quotidian hemodialysis. Am J Kidney Dis. 2003;42:18–23.

    PubMed  Google Scholar 

  271. Saad E, Charra B, Raj DS. Hypertension control with daily dialysis. Semin Dial. 2004;17:295–8.

    PubMed  Google Scholar 

  272. Lindsay RM. The London, Ontario, daily/nocturnal hemodialysis study. Semin Dial. 2004;17:85–91.

    PubMed  Google Scholar 

  273. Achinger SG, Ayus JC. The role of daily dialysis in the control of hyperphosphatemia. Kidney Int Suppl. 2005;(95):S28–32.

    Google Scholar 

  274. Ok E, Duman S, Asci G, Tumuklu M, Onen Sertoz O, Kayikcioglu M, Toz H, Adam SM, Yilmaz M, Tonbul HZ, Ozkahya M. Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-controlled study. Nephrol Dial Transplant. 2011;26:1287–96.

    PubMed  Google Scholar 

  275. Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb-Rumyantzev AS, Hoy CD, Lockridge Jr RS, Miller BW, Eggers PW, Kutner NG. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a usrds study. Kidney Int. 2009;76:984–90.

    CAS  PubMed  Google Scholar 

  276. Rocco MV, Lockridge Jr RS, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S. The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Kidney Int. 2011;80:1080–91.

    PubMed Central  PubMed  Google Scholar 

  277. Chan CT, Liu PP, Arab S, Jamal N, Messner HA. Nocturnal hemodialysis improves erythropoietin responsiveness and growth of hematopoietic stem cells. J Am Soc Nephrol. 2009;20:665–71.

    PubMed Central  PubMed  Google Scholar 

  278. Bergman A, Fenton SS, Richardson RM, Chan CT. Reduction in cardiovascular related hospitalization with nocturnal home hemodialysis. Clin Nephrol. 2008;69:33–9.

    CAS  PubMed  Google Scholar 

  279. Beecroft JM, Hoffstein V, Pierratos A, Chan CT, McFarlane P, Hanly PJ. Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant. 2008;23:673–9.

    PubMed  Google Scholar 

  280. Cafazzo JA, Leonard K, Easty AC, Rossos PG, Chan CT. Patient-perceived barriers to the adoption of nocturnal home hemodialysis. Clin J Am Soc Nephrol. 2009;4:784–9.

    PubMed Central  PubMed  Google Scholar 

  281. Suri RS, Lindsay RM, Bieber BA, Pisoni RL, Garg AX, Austin PC, Moist LM, Robinson BM, Gillespie BW, Couchoud CG, Galland R, Lacson Jr EK, Zimmerman DL, Li Y, Nesrallah GE. A multinational cohort study of in-center daily hemodialysis and patient survival. Kidney Int. 2013;83:300–7.

    PubMed  Google Scholar 

  282. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005;16:2778–88.

    CAS  PubMed  Google Scholar 

  283. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363:2287–300.

    CAS  PubMed  Google Scholar 

  284. Jaber BL, Finkelstein FO, Glickman JD, Hull AR, Kraus MA, Leypoldt JK, Liu J, Gilbertson D, McCarthy J, Miller BW, Moran J, Collins AJ. Scope and design of the following rehabilitation, economics and everyday-dialysis outcome measurements (freedom) study. Am J Kidney Dis. 2009;53:310–20.

    PubMed  Google Scholar 

  285. Jaber BL, Lee Y, Collins AJ, Hull AR, Kraus MA, McCarthy J, Miller BW, Spry L, Finkelstein FO. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: Interim report from the freedom (following rehabilitation, economics and everyday-dialysis outcome measurements) study. Am J Kidney Dis. 2010;56:531–9.

    PubMed  Google Scholar 

  286. Abdel-Kader K, Unruh ML. Benefits of short daily home hemodialysis in the freedom study: is it about person, place, time, or treatment? Kidney Int. 2012;82:511–3.

    PubMed  Google Scholar 

  287. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046–53.

    PubMed  Google Scholar 

  288. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrell PC. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans. 1991;37:598–604.

    CAS  PubMed  Google Scholar 

  289. Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Effects of an angiotensin ii receptor blocker, valsartan, on residual renal function in patients on capd. Am J Kidney Dis. 2004;43:1056–64.

    CAS  PubMed  Google Scholar 

  290. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–64.

    CAS  PubMed  Google Scholar 

  291. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, Movilli E, Pola A, d’Avolio G, Gelatti U. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in capd and hd patients. A longitudinal study. Nephrol Dial Transplant. 1995;10:2295–305.

    CAS  PubMed  Google Scholar 

  292. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the canusa study. J Am Soc Nephrol. 2001;12:2158–62.

    CAS  PubMed  Google Scholar 

  293. McCafferty K, Fan S, Davenport A. Extracellular volume expansion, measured by multifrequency bioimpedance, does not help preserve residual renal function in peritoneal dialysis patients. Kidney Int. 2014;85:151–7.

    PubMed  Google Scholar 

  294. Van Biesen W, Lameire N, Verbeke F, Vanholder R. Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest? J Nephrol. 2008;21:299–304.

    PubMed  Google Scholar 

  295. Wang AY, Lam CW, Wang M, Woo J, Chan IH, Lui SF, Sanderson JE, Li PK. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis. 2005;45:715–29.

    CAS  PubMed  Google Scholar 

  296. Wang AY, Woo J, Wang M, Sea MM, Sanderson JE, Lui SF, Li PK. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant. 2005;20:396–403.

    PubMed  Google Scholar 

  297. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on capd independently of residual renal function. Nephrol Dial Transplant. 1998;13:962–8.

    CAS  PubMed  Google Scholar 

  298. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus JM. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis. 1999;33:523–34.

    CAS  PubMed  Google Scholar 

  299. Huang WH, Chen KH, Hsu CW, Chen YC, Hung CC, Huang JY, Lin JL, Yang CW. Residual renal function – one of the factors associated with arterial stiffness in peritoneal dialysis patients. Insight from a retrospective study in 146 peritoneal dialysis patients. Blood Purif. 2008;26:133–7.

    PubMed  Google Scholar 

  300. Wang AY, Woo J, Sea MM, Law MC, Lui SF, Li PK. Hyperphosphatemia in chinese peritoneal dialysis patients with and without residual kidney function: what are the implications? Am J Kidney Dis. 2004;43:712–20.

    PubMed  Google Scholar 

  301. Gunal AI, Duman S, Ozkahya M, Toz H, Asci G, Akcicek F, Basci A. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001;37:588–93.

    CAS  PubMed  Google Scholar 

  302. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013;83:949–58.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrology Clinic, Dialysis and Renal Transplant Center, C.I. Parhon University Hospital, Gr. T. Popa Univesity of Medicine and Pharmacy, Bdul Carol Nr 50, Iasi, 700506, Romania

    Mihaela Dora Donciu MD, Luminita Voroneanu MD, PhD & Adrian Covic MD, PhD, FRCP (London), FERA

Authors
  1. Mihaela Dora Donciu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luminita Voroneanu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adrian Covic MD, PhD, FRCP (London), FERA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mihaela Dora Donciu MD .

Editor information

Editors and Affiliations

  1. Renal and Transplantation Department, Guy's Hospital, London, United Kingdom

    David Goldsmith

  2. Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania

    Adrian Covic

  3. Karolinska Institutet Danderyd University Hospital, Stockholm, Sweden

    Jonas Spaak

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Donciu, M.D., Voroneanu, L., Covic, A. (2015). Volume Overload in CKD: Pathophysiology, Assessment Techniques, Consequences and Treatment. In: Goldsmith, D., Covic, A., Spaak, J. (eds) Cardio-Renal Clinical Challenges. Springer, Cham. https://doi.org/10.1007/978-3-319-09162-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09162-4_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09161-7

  • Online ISBN: 978-3-319-09162-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation